Edition:
United Kingdom

Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

3.66USD
25 Apr 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$3.66
Open
$3.70
Day's High
$3.70
Day's Low
$3.62
Volume
134,817
Avg. Vol
95,597
52-wk High
$32.25
52-wk Low
$3.45

About

Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways... (more)

Overall

Beta: --
Market Cap(Mil.): $124.85
Shares Outstanding(Mil.): 33.56
Dividend: --
Yield (%): --

Financials

  APTX.OQ Industry Sector
P/E (TTM): -- 62.05 62.41
EPS (TTM): -1.61 -- --
ROI: -43.91 12.20 11.81
ROE: -97.23 13.14 12.64

Allergan depression treatment fails studies, shares slip

Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019

UPDATE 2-Allergan depression treatment fails studies, shares slip

March 6 Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019

Earnings vs. Estimates